Search

Your search keyword '"Pouw, Roos"' showing total 736 results

Search Constraints

Start Over You searched for: Author "Pouw, Roos" Remove constraint Author: "Pouw, Roos"
736 results on '"Pouw, Roos"'

Search Results

101. Dysplastic Recurrence After Successful Treatment for Early Barrett's Neoplasia: Development and Validation of a Prediction Model

102. Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett's Esophagus With Early Neoplasia

103. Impact of expert center endoscopic assessment of confirmed low grade dysplasia in Barrett's esophagus diagnosed in community hospitals

104. Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: Results from the national Dutch database in a 10-year period

105. Incidence and outcomes of poor healing and poor squamous regeneration after radiofrequency ablation therapy for early Barrett's neoplasia

106. Novel cryoballoon 180 degrees ablation system for treatment of Barrett's esophagus-related neoplasia: a first-in-human study: A first-in-human study

107. Extending treatment criteria for Barrett's neoplasia: results of a nationwide cohort of 138 endoscopic submucosal dissection procedures

108. Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green

109. Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study

114. List of Contributors

116. ENDOSCOPIC VACUUM THERAPY for ANASTOMOTIC LEAKAGE after UPPER GASTROINTESTINAL SURGERY

118. OPTICAL EVALUATION CANNOT DISTINGUISH BETWEEN T1A AND T1B ESOPHAGEAL ADENOCARCINOMA: AN INTERNATIONAL EXPERT INTER-OBSERVER AGREEMENT STUDY.

121. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)

123. NEOPLASTIC RECURRENCE AFTER SUCCESSFUL TREATMENT FOR EARLY BARRETT'S NEOPLASIA: DEVELOPMENT OF A PENALIZED PREDICTION MODEL

124. Endoscopic tissue sampling – Part 2: Lower gastrointestinal tract. European Society of Gastrointestinal Endoscopy (ESGE) Guideline

125. Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma

126. Extension of early esophageal squamous cell neoplasia into ducts and submucosal glands and the role of endoscopic ablation therapy

127. Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline

129. ID: 3521795 ENDOSCOPIC EXPERT REVISION OF PREVIOUS HISTOLOGICAL CONFIRMED FLAT LOW-GRADE DYSPLASIA IN BARRETT’S ESOPHAGUS

131. ID: 3521940 ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT'S RELATED NEOPLASIA IN THE NETHERLANDS: RESULTS OF A NATIONWIDE COHORT OF 130 CASES

132. ID: 3520201 POOR HEALING AND POOR SQUAMOUS REGENERATION AFTER RADIOFREQUENCY ABLATION THERAPY FOR EARLY BARRETT'S NEOPLASIA: INCIDENCE, RISK FACTORS AND OUTCOMES

133. Incidence and outcomes of poor healing and poor squamous regeneration after radiofrequency ablation therapy for early Barrett’s neoplasia

134. Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green

135. 43 TISSUECYPHER OBJECTIVELY RISK STRATIFIES BARRETT'S ESOPHAGUS PATIENTS WITH LOW GRADE DYSPLASIA

136. 41 NEOPLASTIC RECURRENCE AFTER SUCCESSFUL TREATMENT FOR EARLY BARRETT'S NEOPLASIA: DEVELOPMENT OF A PENALIZED PREDICTION MODEL

137. A computer-assisted algorithm for narrow-band-imaging–based tissue characterization in Barrett’s esophagus

138. Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma:A multicenter cohort study

139. Favorable effect of endoscopic reassessment of clinically staged T2 esophageal adenocarcinoma:A multicenter prospective cohort study

140. Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma

141. ID: 3520201 POOR HEALING AND POOR SQUAMOUS REGENERATION AFTER RADIOFREQUENCY ABLATION THERAPY FOR EARLY BARRETT'S NEOPLASIA: INCIDENCE, RISK FACTORS AND OUTCOMES

142. Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma

143. ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT'S RELATED NEOPLASIA IN THE NETHERLANDS: RESULTS OF A NATIONWIDE COHORT OF 130 CASES

144. Extension of early esophageal squamous cell neoplasia into ducts and submucosal glands and the role of endoscopic ablation therapy

145. Toward improved endoscopic surveillance with multidiameter single fiber reflectance spectroscopy in patients with Barrett's esophagus

147. Performance of gastrointestinal pathologists within a national digital review panel for Barrett's oesophagus in the Netherlands: results of 80 prospective biopsy reviews

150. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients

Catalog

Books, media, physical & digital resources